@WHO: WHO’s emergency use listing procedure assesses the quality, safety and efficacy of #COVID19 vaccines and is a prerequisite for #COVAX vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. https://t.co/1sCdSMx7RF

http://twitter.com/WHO
via IFTTT